FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W1978820185> ?p ?o ?g. }

• W1978820185 endingPage "29679" @default.
• W1978820185 startingPage "29670" @default.
• W1978820185 abstract "The C1 domain of factor VIII (FVIII) has been implicated in binding to multiple constituents, including phospholipids, von Willebrand factor, and low-density lipoprotein receptor-related protein (LRP). We have previously described a human monoclonal antibody called KM33 that blocks these interactions as well as cellular uptake by LRP-expressing cells. To unambiguously identify the apparent “hot spot” on FVIII to which this antibody binds, we have employed hydrogen-deuterium exchange mass spectrometry. The results showed that KM33 protects FVIII regions 2091–2104 and 2157–2162 from hydrogen-deuterium exchange. These comprise the two C1 domain spikes 2092–2093 and 2158–2159. Spike 2092–2093 has been demonstrated recently to contribute to assembly with lipid membranes with low phosphatidylserine (PS) content. Therefore, spike 2158–2159 might serve a similar role. This was assessed by replacement of Arg-2159 for Asn, which introduces a motif for N-linked glycosylation. Binding studies revealed that the purified, glycosylated R2159N variant had lost its interaction with antibody KM33 but retained substantial binding to von Willebrand factor and LRP. Cellular uptake of the R2159N variant was reduced both by LRP-expressing U87-MG cells and by human monocyte-derived dendritic cells. FVIII activity was virtually normal on membranes containing 15% PS but reduced at low PS content. These findings suggest that the C1 domain spikes 2092–2093 and 2158–2159 together modulate FVIII membrane assembly by a subtle, PS-dependent mechanism. These findings contribute evidence in favor of an increasingly important role of the C1 domain in FVIII biology.Background: Antibody KM33 blocks factor VIII (FVIII) endocytosis and phospholipid binding.Results: Hydrogen-deuterium exchange mass spectrometry reveals that KM33 binds C1 domain spikes 2092–2093 and 2158–2159. Glycosylated FVIII-R2159N shows reduced endocytosis and decreased binding to phospholipid membranes with low phosphatidylserine content.Conclusion: Spikes 2092–2093 and 2158–2159 modulate FVIII endocytosis and phospholipid binding.Significance: Novel insight is obtained about the role of the C1 domain for FVIII biology. The C1 domain of factor VIII (FVIII) has been implicated in binding to multiple constituents, including phospholipids, von Willebrand factor, and low-density lipoprotein receptor-related protein (LRP). We have previously described a human monoclonal antibody called KM33 that blocks these interactions as well as cellular uptake by LRP-expressing cells. To unambiguously identify the apparent “hot spot” on FVIII to which this antibody binds, we have employed hydrogen-deuterium exchange mass spectrometry. The results showed that KM33 protects FVIII regions 2091–2104 and 2157–2162 from hydrogen-deuterium exchange. These comprise the two C1 domain spikes 2092–2093 and 2158–2159. Spike 2092–2093 has been demonstrated recently to contribute to assembly with lipid membranes with low phosphatidylserine (PS) content. Therefore, spike 2158–2159 might serve a similar role. This was assessed by replacement of Arg-2159 for Asn, which introduces a motif for N-linked glycosylation. Binding studies revealed that the purified, glycosylated R2159N variant had lost its interaction with antibody KM33 but retained substantial binding to von Willebrand factor and LRP. Cellular uptake of the R2159N variant was reduced both by LRP-expressing U87-MG cells and by human monocyte-derived dendritic cells. FVIII activity was virtually normal on membranes containing 15% PS but reduced at low PS content. These findings suggest that the C1 domain spikes 2092–2093 and 2158–2159 together modulate FVIII membrane assembly by a subtle, PS-dependent mechanism. These findings contribute evidence in favor of an increasingly important role of the C1 domain in FVIII biology. Background: Antibody KM33 blocks factor VIII (FVIII) endocytosis and phospholipid binding. Results: Hydrogen-deuterium exchange mass spectrometry reveals that KM33 binds C1 domain spikes 2092–2093 and 2158–2159. Glycosylated FVIII-R2159N shows reduced endocytosis and decreased binding to phospholipid membranes with low phosphatidylserine content. Conclusion: Spikes 2092–2093 and 2158–2159 modulate FVIII endocytosis and phospholipid binding. Significance: Novel insight is obtained about the role of the C1 domain for FVIII biology." @default.
• W1978820185 created "2016-06-24" @default.
• W1978820185 creator A5017642120 @default.
• W1978820185 creator A5042863699 @default.
• W1978820185 creator A5051104659 @default.
• W1978820185 creator A5056038004 @default.
• W1978820185 creator A5072522782 @default.
• W1978820185 creator A5074112020 @default.
• W1978820185 creator A5074969584 @default.
• W1978820185 creator A5082243444 @default.
• W1978820185 creator A5083685180 @default.
• W1978820185 date "2013-10-01" @default.
• W1978820185 modified "2023-10-03" @default.
• W1978820185 title "Factor VIII C1 Domain Spikes 2092–2093 and 2158–2159 Comprise Regions That Modulate Cofactor Function and Cellular Uptake" @default.
• W1978820185 cites W152180060 @default.
• W1978820185 cites W1891870091 @default.
• W1978820185 cites W1896702999 @default.
• W1978820185 cites W1936207504 @default.
• W1978820185 cites W1974389101 @default.
• W1978820185 cites W1975768977 @default.
• W1978820185 cites W1983094339 @default.
• W1978820185 cites W2002741069 @default.
• W1978820185 cites W2015041168 @default.
• W1978820185 cites W2025760623 @default.
• W1978820185 cites W2037289647 @default.
• W1978820185 cites W2040257513 @default.
• W1978820185 cites W2044694095 @default.
• W1978820185 cites W2051757097 @default.
• W1978820185 cites W2053492054 @default.
• W1978820185 cites W2060639270 @default.
• W1978820185 cites W2061785001 @default.
• W1978820185 cites W2064974916 @default.
• W1978820185 cites W2066775733 @default.
• W1978820185 cites W2067564649 @default.
• W1978820185 cites W2071018055 @default.
• W1978820185 cites W2083974381 @default.
• W1978820185 cites W2089293026 @default.
• W1978820185 cites W2095498248 @default.
• W1978820185 cites W2114320763 @default.
• W1978820185 cites W2121293250 @default.
• W1978820185 cites W2123774727 @default.
• W1978820185 cites W2128539167 @default.
• W1978820185 cites W2131289400 @default.
• W1978820185 cites W2136078026 @default.
• W1978820185 cites W2147024375 @default.
• W1978820185 cites W2149513936 @default.
• W1978820185 cites W2154181324 @default.
• W1978820185 cites W2157140221 @default.
• W1978820185 cites W2166225023 @default.
• W1978820185 cites W2409286460 @default.
• W1978820185 cites W4230915316 @default.
• W1978820185 cites W4249629479 @default.
• W1978820185 doi "https://doi.org/10.1074/jbc.m113.473116" @default.
• W1978820185 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/3795264" @default.
• W1978820185 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/24009077" @default.
• W1978820185 hasPublicationYear "2013" @default.
• W1978820185 type Work @default.
• W1978820185 sameAs 1978820185 @default.
• W1978820185 citedByCount "42" @default.
• W1978820185 countsByYear W19788201852013 @default.
• W1978820185 countsByYear W19788201852014 @default.
• W1978820185 countsByYear W19788201852015 @default.
• W1978820185 countsByYear W19788201852016 @default.
• W1978820185 countsByYear W19788201852017 @default.
• W1978820185 countsByYear W19788201852018 @default.
• W1978820185 countsByYear W19788201852019 @default.
• W1978820185 countsByYear W19788201852020 @default.
• W1978820185 countsByYear W19788201852021 @default.
• W1978820185 countsByYear W19788201852022 @default.
• W1978820185 countsByYear W19788201852023 @default.
• W1978820185 crossrefType "journal-article" @default.
• W1978820185 hasAuthorship W1978820185A5017642120 @default.
• W1978820185 hasAuthorship W1978820185A5042863699 @default.
• W1978820185 hasAuthorship W1978820185A5051104659 @default.
• W1978820185 hasAuthorship W1978820185A5056038004 @default.
• W1978820185 hasAuthorship W1978820185A5072522782 @default.
• W1978820185 hasAuthorship W1978820185A5074112020 @default.
• W1978820185 hasAuthorship W1978820185A5074969584 @default.
• W1978820185 hasAuthorship W1978820185A5082243444 @default.
• W1978820185 hasAuthorship W1978820185A5083685180 @default.
• W1978820185 hasBestOaLocation W19788201851 @default.
• W1978820185 hasConcept C153911025 @default.
• W1978820185 hasConcept C159654299 @default.
• W1978820185 hasConcept C185592680 @default.
• W1978820185 hasConcept C203014093 @default.
• W1978820185 hasConcept C2779394231 @default.
• W1978820185 hasConcept C55493867 @default.
• W1978820185 hasConcept C86803240 @default.
• W1978820185 hasConcept C89560881 @default.
• W1978820185 hasConcept C95444343 @default.
• W1978820185 hasConceptScore W1978820185C153911025 @default.
• W1978820185 hasConceptScore W1978820185C159654299 @default.
• W1978820185 hasConceptScore W1978820185C185592680 @default.
• W1978820185 hasConceptScore W1978820185C203014093 @default.
• W1978820185 hasConceptScore W1978820185C2779394231 @default.
• W1978820185 hasConceptScore W1978820185C55493867 @default.
• W1978820185 hasConceptScore W1978820185C86803240 @default.
• W1978820185 hasConceptScore W1978820185C89560881 @default.

• next